Avidity Partners Management LP Arcus Biosciences, Inc. Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$17.23 - $37.73 $15.7 Million - $34.4 Million
-912,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$28.92 - $41.83 $26.4 Million - $38.1 Million
912,000 New
912,000 $28.8 Million
Q3 2020

Nov 16, 2020
SELL
$17.14 - $25.47 $10.1 Million - $15 Million
-589,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$13.97 - $36.56 $8.23 Million - $21.5 Million
589,000 New
589,000 $14.6 Million

Others Institutions Holding RCUS

# of Institutions
196
Shares Held
51.7M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $931M
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email